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Abstract
Background: Pulmonary surfactant is required for lung function at birth and throughout life. Lung lipid and
surfactant homeostasis requires regulation among multi-tiered processes, coordinating the synthesis of surfactant
proteins and lipids, their assembly, trafficking, and storage in type II cells of the lung. The mechanisms regulating
these interrelated processes are largely unknown.
Results: We integrated mRNA microarray data with array independent knowledge using Gene Ontology (GO)
similarity analysis, promoter motif searching, protein interaction and literature mining to elucidate genetic networks
regulating lipid related biological processes in lung. A Transcription factor (TF) - target gene (TG) similarity matrix
was generated by integrating data from different analytic methods. A scoring function was built to rank the likely
TF-TG pairs. Using this strategy, we identified and verified critical components of a transcriptional network directing
lipogenesis, lipid trafficking and surfactant homeostasis in the mouse lung.
Conclusions: Within the transcriptional network, SREBP, CEBPA, FOXA2, ETSF, GATA6 and IRF1 were identified as
regulatory hubs displaying high connectivity. SREBP, FOXA2 and CEBPA together form a common core regulatory
module that controls surfactant lipid homeostasis. The core module cooperates with other factors to regulate lipid
metabolism and transport, cell growth and development, cell death and cell mediated immune response.
Coordinated interactions of the TFs influence surfactant homeostasis and regulate lung function at birth.
Background
Pulmonary surfactant is a lipid-protein complex that is
synthesized by type II epithelial cells in the alveoli. Sur-
factant is stored in intracellular organelles known as
lamellar bodies and is secreted into airspace by exocyto-
sis. Surfactant lipids form monolayer and multilayer that
line the alveolar surface, reducing surface tension cre-
ated at the air-liquid interface. Pulmonary surfactant is
essential for the proper inflation and function of the
lung [1]. Surfactant deficiency is associated with prema-
ture birth, lung infection or injury. Mutations in genes
critical for surfactant production or function can cause
lung atelectasis and respiratory failure [2]. Surfactant
homeostasis is maintained by a balance among multi-
tiered processes, including the synthesis assembly, traf-
ficking, storage, secretion recycling and degradation of
surfactant proteins and lipids. While the structures and
functions of pulmonary surfactant proteins and lipids
have been extensively studied, little is known regarding
the genetic and cellular mechanisms integrating the
complex processes controlling surfactant lipid
homeostasis.
Transcriptional regulation of lipogenesis has been
extensively studied in the liver and adipocytes. A num-
ber of TFs have been identified controlling the expres-
sion of lipogenic enzymes and genes in the lipogenic
pathways including Sterol Regulatory Element Binding
Protein (SREBP) isoforms, CCAAT-enhancer binding
protein (C/EBP) isoforms, nuclear hormone receptors
(NR1H2 and NR1H3) and peroxisome proliferator acti-
vated receptors (PPAR) [3-7]. SREBP has two genes
(Srebf1 and 2) encoding for three protein isoforms,
SREBP-1a, SREBP-1c and SREBP-2. SREBPs are synthe-
sized as inactive precursors and activated by proteolysis
in the Golgi apparatus. SREBP-2 primarily activates cho-
lesterol biosynthetic genes whereas SREBP-1c predomi-
nantly activates genes involved in fatty acid production
[4]. The C/EBPs belong to the basic-leucine zipper class
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act as homo-or heterodimers via highly conserved bZIP
domain [8]. The involvement of C/EBPs in lipogenesis is
strongly supported by both in vitro and in vivo data. In
adipocytes, C/EBPa, SREBP-1c and PPARg induce fatty
acid biosynthesis, but only C/EBPa is essential [9].
Lung maturation is highly dependent on the differen-
tiation and function of the respiratory epithelium that,
in turn, produces pulmonary surfactant lipids and pro-
teins. Studies from the conditional deletion or mutation
of specific genes have lead to the identification of sev-
eral TFs in lung epithelium that are crucial to lung
maturation and respiratory adaptation, include TTF-1,
FOXA2 and C/EBPa. TTF-1 binds to the promoters of
lung specific genes such as Sftpa, Sftpb, Sftpc, Sftpd and
Scgb1a1 and increases their expression [10,11]. The
deletion of Foxa2 or Cebpa from lung epithelial cells
resulted in the lack of surfactant lipids and proteins,
lack of appropriate differentiation of type I and II cells
and absence of lamellar body formation, indicating
delayed peripheral lung maturation [12,13]. Comparative
microarray analysis show that although these TFs bind
to distinct cis-elements in the promoter region of target
genes, they are able to influence the expression of many
common targets involved in surfactant proteins and
lipid biosynthesis (e.g, Abca3, Scd1, Pon1, Sftpa, Sftpb,
Sftpc and Sftpd), fluid and solute transport (e.g., Aqp5,
Scnn1g, Slc34a2) and innate host defense (e.g., Lys,
Sftpa, Sftpd and Scgb1a1), suggesting that Foxa2,
CEBPa and Titf1 may share common transcription net-
work regulating perinatal lung maturation and postnatal
adaptation [12-15]. The majority of information regard-
ing the role of SREBP has been focused to cholesterol
and fatty acid metabolism in tissues such as liver and
adipose [4,16,17]. SREBP-1c is expressed in the develop-
ing lung, where its expression increases during late
gestation, concomitantly with the perinatal increases in
surfactant lipid synthesis and the induction of genes cri-
tical for surfactant function [18,19]. SREBP activates
CTP:phosphocholine cytidylyltransferase, the rate-limit-
ing enzyme for phosphatidylcholine synthesis and
increases surfactant phosphatidylcholine synthesis in the
mouse lung [20-22]. These data strongly support the
notion that in lung, SREBP may play an important role
in surfactant and phospholipid homeostasis.
A fundamental challenge in the “post genomic era” is
to decode transcriptional networks that direct intricate
patterns of gene expression in complex organisms. In
the lung, how TFs interact with each other and signaling
molecules to regulate groups of gene targets mediating
distinct but integrated aspects of cell or organ function,
and how lipid homeostasis is integrated with maturation
of type II epithelial cells remain unclear. It is highly
likely that surfactant lipid homeostasis is controlled by
complex interactions among transcriptional networks
that integrate distinct but interrelated aspects of alveolar
cell biology, e.g., lung maturation, host defense and sur-
factant function. Several strategies have been devised to
decipher regulatory components and networks, each is
partially successful and none is without limitations.
Microarray analysis reveals mRNAs that change signifi-
cantly in expression, but fails to assign these changes to
biological events. The GO annotation and literature
mining enable the association of genes with biological
processes and pathways, but are limited to current
knowledge. TF-TG correlation takes into account that
expression profiles of TFs and their targets are often
correlated and genes with highly correlated profiles are
likely to be regulated by the same TF(s). In some
instances, however, TFs regulate their targets, not by
changing their own expression, but by post-transcrip-
tional mechanisms such as transcript stability, binding
site accessibility, interaction with tissue-specific co-fac-
tors or chromatin structures [23,24]. Promoter analysis
seeking conserved or common TFBSs in promoters of
co-expressed genes can identify the potential cis-ele-
ments, but may not inherently identify the binding TF
or its role in transcription; moreover, this analysis is
often associated with high numbers of false positive pre-
dictions due to the short and degenerate nature of many
TFBS motifs. In the present study, we sought biological
consistency and comprehensiveness by using a systems
approach to integrate analytic results from independent
and complementary resources, including gene expres-
sion profiling, protein interaction, functional annotation,
promoter and literature mining, to develop a map of
genetic networks regulating lung lipogenesis and surfac-
tant homeostasis that are critical for lung function,
focusing on the roles of key TFs in the network.
Results and Discussion
We retrieved microarray data from a lung specific gene
expression database that measures lung mRNA
responses to genetic modification of various genes
important to lung development and function (see “Data
collection, processing and storage”). Total of 194 mRNA
microarray samples from 27 distinct mouse models were
used in this study (Table 1).
Clustering and functional classification revealed three
lipid enriched gene clusters
Cluster analysis grouped 1498 genes that significantly
changed in response to various gene perturbations into
29 clusters (Additional file 1). Genes in each cluster
were further classified according to GO classification by
Biological Processes to test the biological relevance of
each cluster. The criteria for an enriched functional
class were P < 0.01 in Fisher Exact Test, the functional
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cluster. Most clusters (26/29) had enriched functional
classes according to the criteria, indicating their func-
tional coherence within each cluster (Table 2).
In the present study, we sought to identify the tran-
scription networks regulating perinatal surfactant lipid
homeostasis. “Lipid biosynthesis/metabolism/transport”
was enriched in 4 out of 29 clusters and SREBP was a
member in three of the clusters. We chose to focus on
three SREBP related lipid clusters (C1, C2 and C28) for
compactness and simplicity of the network (C23 was
not included since SREBP was not in the cluster and
lipid metabolism was not the predominant functional
class of this cluster).
In addition to the commonly enriched functions, i.e.
“lipid biosynthesis and metabolism”, each cluster has its
uniquely enriched functionality (Table 3). Cluster 1 is
functionally enriched in “lung” and “vascular” develop-
ment, with corresponding mouse phenotypes that
include “abnormal vascular development, alveolar mor-
phology and respiratory mechanics”. Membrane/Insolu-
ble fraction is the most enriched cellular component in
cluster 1. Cluster 2 is the smallest cluster among the
three and is enriched for “lipid metabolism and lipid
transport”. Mouse phenotypes associated with the clus-
ter 2 include “abnormal respiratory alveolar morphology
and abnormal lipid homeostasis”. “Endoplasmic reticu-
lum (ER)” is the most enriched cellular component in
this gene cluster. Tissue distribution analysis indicated
that the expression of genes in this cluster is most abun-
dantly expressed in the lung. These functional annota-
tions aligned well with the fact that surfactant lipid and
proteins are synthesized and assembled in the ER of
alveolar type II cells. Cluster 28 is functionally enriched
in “lipid metabolism” and “response to external/chemical
stimulus”, the corresponding mouse phenotype being
“abnormal blood chemistry and alveolar morphology”.
Overall, the functional classifications indicate that lung
Table 1 Microarray Data Used In This Study
Array Name Investigator Mouse Model Reference
CEBPA_KO Ikegami Cebpa
Δ/Δ mice: (tetO)7CMV-Cre
-/tg/SP-C-rtTA
-/tg/Cebpa
flox/flox, E18.5 Martis, et al. 2006
CNB Dave Cnb
Δ/Δ mice: CCSP-rtTA/(tetO)7CMV-Cre/Cnb1
flox/flox Dave, et al. 2006
CTNNB1_ACT Mucenski Catnb
Δ (ex3) mice: CCSP-rtTA
+/tg or tg/tg, (tetO)7CMV-Cre
+/tg or tg/tg, Catnb
+/Δ (ex3) Mucenski, et al. 2005
CTNNB1_KO Mucenski SP-C-rtTA
+/tg,( tetO)
7-CMV-Cre
+/tg or tg/tg, b-catenin
flx/flx Mucenski, et al. 2003
Cyclopamine_
Effect
Shannon Lung explant culture treated with Cyclopamine for 1-3 days
D508 Whitsett CFTR
Δ508 mice: FABP-hCFTR
+/-/mCftr
-/-/SP-C-Δ508CFTR
+/+ Xu, et al. 2006
FGF18_OE Whitsett SP-C-rtTA and (teto)7CMV-FGF-18 Whitsett, et al. 2002
Fgfr2IIIb Perl SP-C-rtTA and (teto)7CMV-Fgfr2IIIb
flx/flx; E11.5-13.5 lung Perl, et al. 2003
FoxA2_KO Whitsett Foxa2
Δ/Δ mice: SPC-rtTA
-/tg/(tetO)7Cre
-/tg/Foxa2
LoxP/LoxP; E18.5 Wan, et al. 2004
FoxaDKO Whitsett Foxa2
Δ/Δ, Foxa1
-/- mice: Foxa1
-/-/SPC-rtTA
-/tg/(tetO)7Cre
-/tg/Foxa2
LoxP/LoxP ; E14.5 Wan, et al. 2005
FoxM1_KO Whitsett Foxm1-/- mice; E18.5 Wang, et al.
HIF1KO Shannon Hif1
Δ/Δ mice: SPC-rtTA
-/tg/(tetO)7Cre
-/tg/Hif1
flx/flx; PND1
LAL Yan Lal-/- mice, 4month Lian, et al. 2004
MIA Shannon tetO7-Cre/SPC-rtTA/Mia1, E18.5 Lin, et al. 2008
SHH12.5 Shannon Shh-/- mice; E12.5
SHH13.5 Whitsett Shh
Δ/Δ mice: SP-C-rtTA
tg/(tetO)7CMV-Cre
tg/tg/Shh
flx/flx; E13.5 Miller, et al. 2004
SHH18.5 Whitsett Shh
Δ/Δ mice: SP-C-rtTA
tg/(tetO)7CMV-Cre
tg/tg/Shh
flx/flx; E18.5 Miller, et al. 2004
SPA_KO Levine alveolar macrophage from Sftpa -/- mice
SPC_2M Glasser Sftpc-/- mice; 2month Glasser, et al. 2003
SPC_PND1 Glasser Sftpc-/- mice, PND1 Glasser, et al. 2008
SPC_typeII Glasser Isolated typeII cells from Sftpc -/- mice Glasser, et al. 2003
SPD_AM Whitsett Isolated alveolar macrophage from Sftpd-/- mice Zhang, et al. 2006
SPD_typeII Ikegami isolated typeII cell from Sftpd -/- mice Korfhagen, et al. 1998
Stat3_tyII Ikegami Type II cells from TetO7Cre/SPC-rtTA/Stat3
flox/flox, 7 week. Xu, et al. 2007
SU5402 Shannon Lung explant culture treated with 0.1% DMSO or SU5402, E12.5 Metzger, et al. 2007
TTF1_Lung Whitsett Titf1
PM/PM mice:Titf1 phosphorylation mutant, E18.5 lung DeFelice, et al. 2003
TTF1_Thyroid Whitsett Titf1
PM/PM mice:Titf1 phosphorylation mutant, E18.5 thyroid
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ment and is required for various stress responses.
Identification of commonly enriched TFBS
In general, transcriptional regulation is mediated by the
binding of TF or their partners to specific binding sites
(TFBS) in the regulatory regions of the target genes
(TG). The TFBSs are often located in close proximity to
the transcription start site (TSS), but sometimes can be
located at more remote locations [25-27]. It is assumed
that functional TFBS are subject to greater selective
pressure, and therefore will be evolutionarily conserved
across species [28-30]. To identify over-represented
T F B S si nag i v e nc l u s t e r ,w et o o kt h r e ea p p r o a c h e s .
First, we searched 3 kb upstream genomic sequence for
TFBS in the evolutionarily conserved regions (ECR) that
are over-represented in a gene cluster [28,31]. We then
searched proximal promoter regions (1.2 kb) for over-
represented TFBS in the cluster [32]. We also deter-
mined the over-represented TFBS frequency in the
proximal promoter region for each gene in the cluster.
The relative importance of a TFBS was determined by
the average ranking order of the ECR, promoter and fre-
quency analysis. The results are summarized in Figure 1.
TFBS for CEBP (CCAAT/Enhancer Binding Protein
Family), HNF3B (FOXA2) and SREBP (SREBF1/2) are
common to all three clusters, likely indicating the uni-
versal roles of these factors in lung lipid metabolism.
TFBS for TTF1, HNF3 (FOXA1/2), TCF4, SOX9 and
BARBIE (barbiturate-inducible element) were commonly
enriched in cluster 1 and 2 genes. The enrichment of
this group of TFBS in cluster 1 and 2 gene promoters
may indicate their related roles in lung development
and morphogenesis. In addition to commonly enriched
TFBS among the clusters, we identified TFBS uniquely
enriched for each cluster. For example, CIZ (Cas-asso-
ciated zinc finger protein), OCT (POU2F1) and ETS2
were unique to C1 genes; HNF1 and EGR1 were unique
to C2 genes; NFAT and STAT6 were unique to C28
genes. This was consistent with the finding that the
three clusters have shared as well as unique
functionalities.
Determination of TF-TG functional similarity and
expression correlation
It is assumed that genes share similar annotations are
likely to be involved in similar biological processes. We
used kappa statistics to quantitatively measure the
degree of agreement how TF-TG sharing annotation
terms [33]. Kappa result ranges from 0 to 1. The higher
the value of Kappa, the stronger the agreement is. The
Table 2 Functional Classification of Gene Clusters
BioProcess Clusters
Carbohydrate/organic acid metabolism 23, 24
cell adhesion 1,3,23,24
cell cycle 14,15,16
cell differentiation 1,10
cell migration/motility 3
defense response 10,20,21,22
development 1,3,10,19,23,27,28
DNA metabolism/replication 14,15
localization/transport 1, 3, 10,28
lipid metabolism 1, 2, 23,28
metabolism 5,6,8,9,12,13,14,15,16,17,23,24,28
morphogenesis 1,23,24,27,28
negative regulation of biological
process
13,23,24
Regulation (Transcription/signaling) 5,6,9,11,14,15,16,18, 19, 23, 24
protein modification 12
regulation of cell size 24
RNA splicing 7
cytoskeleton organization and
biogenesis
19, 24
blood vessel development 3,19
Clusters listed in Additional file 1 were subject to Gene Ontology analysis
http://david.abcc.ncifcrf.gov/ to determine the extent of enrichment of
biological function among genes in each cluster. Clusters sharing biological
functions were grouped together according to the function. Shown in the
table are enriched functional classes with enrichment p-value < 0.01 and
shared by more than 20% of the genes in the cluster.
Table 3 Clusters Feature Comparison
Cluster
name
Gene
Number
Function and Process Mouse Phenotype Cell Components
C1 313 Lipid biosynthesis; Morphogenesis; Differentiation;
Proliferation; Lung and respiratory tube
development; Vascular development
Abnormal vasculature development; Abnormal
cardiovascular physiology; Abnormal alveolar
morphology; Abnormal respiratory mechanics
Insoluble fraction;
Membrane fraction
C2 54 Lipid Metabolism; Lipid Transport Abnormal respiratory alveolar morphology; Abnormal
lipid homeostasis
Endoplasmic
reticulum
C28 205 Response to external stimulus; Lipid metabolic
process
Abnormal blood chemistry Insoluble fraction;
Integral to plasma
membrane
Genes from each cluster were subject to gene set enrichment analysis to identify enriched functions and processes, mouse phenotypes and cell components
http://toppgene.cchmc.org/.
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edgebase http://david.abcc.ncifcrf.gov/. We calculated
the kappa similarity between the enriched TFs of a
given cluster (determined via promoter analysis) and
genes in the same cluster. Table 4 lists top ranked genes
according to their functional similarity (kappa) to that
of Srebf1 and Cebpa.
Expression profiles of transcriptional regulators and
their targets are correlated in many cases, and genes
regulated by the same regulators are likely to be co-
expressed [34-37]. We considered TFs in each cluster as
potential regulators of the genes in the same cluster.
We determined the TF-TG correlations using Pearson
correlation. Srebf1 and Cebpa expression profiles
Figure 1 Identification of over-represented TFBSs in each gene cluster. Upstream genomic sequence (3 kb) was searched for TFBS in
evolutionarily conserved regions (ECR) that are over-represented in a gene cluster. Proximal promoter regions (1.2 kb) were searched for over-
represented TFBS in the cluster. We also determined the over-represented TFBS frequency in the proximal promoter region for each gene in the
cluster. The relative importance of a TFBS was determined by the average ranking order of ECR, prompter and frequency analysis and
normalized to -2.5 to 2.5. A heatmap was generated based on the normalized relative importance of TFBSs. ND: Frequency was not determined
if the TFBS was not enriched in the promoter region of the gene cluster compared to all promoters in the mouse genome used as the
background set (p-value > 0.05).
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Page 5 of 19Table 4 TF-TG functional similarity and expression correlation (CEBPA and SREBP)
CEBPA SREBP
Rank by Kappa
Similarity
Known Targets Rank by
correlation
Known Targets Rank by Kappa
Similarity
known
Targets
Rank by
Correlation
Known
Targets
Cebpa Kyrmizi et al.
2006
Cebpa Kyrmizi et al.
2006
Srebf1 She et al. 2005 Srebf1 She et al.
2005
Foxf1a Kim et al, 2005 S100 g Mtdh Lipg Reed et al.
2008
Foxa1 Lpcat1 Supt16h Wdr81
Ets1 Lefterova et al.
2008
Sftpb Martis et al. 2006 Id2 6330416G13Rik
Sox7 Dlk1 Shimomura et al.
1998
Ebf1 Abca3
Foxa2 Martis et al 2006 Serpinb6b Elf5 Wars Reed et al.
2008
Wwtr1 Timp3 Lefterova et al.
2008
Ankib1 Lyzs
Elf5 Edil3 Fah Serpinf1
Smad5 Abca3 Fli1 Dhcr7 Reed et al.
2008
Tbx4 3110001I20Rik Soat1 Farrell, et al.
2005
Siva1
Fli1 Bex2 Ahr Iwano et al.
2005
Ndst1
Ahr Tspan11 Cdkn2b Cds2
Etv5 Vsnl1 Foxo3 Bcl6b
Id2 Tavor et al. 2003 Cd38 Sox7 Matn4
Runx1t1 Rochford et al
2004
1190002N15Rik Mid1ip1 Ier3
Mef2c Pard6b Cbfa2t3 Scd1 Horton et al.
2002
Ebf1 Jimenez, et al.
2007
Emp2 Mef2c Hck
Klf7 Id2 Tavor et al. 2003 Myb Dag1
Prdm1 Kit Zfx Bcl2a1a
Jun Rangatia et al.
2002
Mme Acsl4 Sox7
Utp11l B3gnt2 Cebpa Pedersen et al.
2007
Ahr Iwano et al.
2005
Tcfcp2l1 Ndst1 Dhcr7 Rab6b
Cbfa2t3 Lyz1 Lefterova et al.
2008
Etv5 Slc1a5
Fos Cammenga et al.
2003
Lyz Lefterova et al.
2008
Foxa1 Slc34a2
Stat3 Numata et al.
2005
Syne2 Foxa2 Enpp2
Sox2 Tgoln1 Rab2 Hdc Ai et al. 2006
Myb Verbeek, et al.
1999
Klf7 Runx1t1 Sftpb
Srebf1 Le et al. 2002 Atp6v1b2 Tbx4 Kdr
Klf9 Me1 Lefterova et al.
2008
Tcfcp2l1 Tsn
Foxo3a Tcfcp2l1 Upk3b Rtkn2
Cdkn2b Rtkn2 Foxf1a Zdhhc14
Ankib1 Krt19 Sox2 Dtna
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ters across various experimental conditions, there were
50 genes correlated with Srebf1 and 60 genes correlated
with Cebpa with a correlation coefficient ≥0.5. Table 4
lists genes whose mRNA expression was strongly corre-
lated with that of Srebf1 and Cebpa in the rank order of
the Pearson product-moment correlation coefficient. As
indicated in the Table 4, regulation of a number of the
t o pr a n k e dg e n e sb ySrebf1 and Cebpa was experimen-
tally confirmed through literature search, indicating TF-
TG functional similarity and expression correlation can
be useful features for TF-TG prediction.
TF-TG functional similarity measure is limited by
known annotations for a given gene. Likewise, correla-
tion does not always hold true. For example, previous
studies using lung selective deletion of Foxa2 in the
mouse demonstrated that Foxa2 is critical for lung
maturation and is involved in the expression regulation
of genes in surfactant lipid synthesis [13]. The promoter
and gene ontology analysis also indicate that Foxa2 is an
important regulator in the mouse lung lipid network.
Foxa2 mRNA levels were poorly correlated with genes
in the lipid clusters, there were only 5 genes that corre-
lated with Foxa2 with a correlation coefficient ≥0.5. We
confirmed by qRT-PCR that Foxa2 mRNA expression
levels do not substantially change during lung matura-
tion (data not shown). TFs can regulate their targets
independently of their own levels of expression, for
example by changing chromatin structure, histone-mod-
ification states, nucleosome positions in vivo, phosphor-
ylation status, and binding site accessibility with other
partners [23,24]. In other words, a positive correlation
between TF and TG provides useful evidence for a regu-
latory relationship; a poor expression correlation does
not necessarily indicate there is no relationship between
a given TF-TG pair. Our predication is based on the
combined evidence from mRNA expression correlation
with promoter profiles and gene ontology similarity; the
latter two methods do not require expression
correlation.
Prediction of Gene Regulatory Interactions via Data
Integration
We then predicted TF-TG interaction based on the inte-
gration of evidence from TF-TG correlations, promoter
TFBS information, TF-TG kappa similarity and TF-TG
interaction evidence. An integrative scoring function
was developed to rank the possibility of TF-TG relation-
ship, and to prioritize and associate each target with its
potential regulators (detail see METHODS section).
Based on these regulatory relationships, we constructed
a lung lipid regulatory network. Using the cut off confi-
dence score of 0.5, the overall connectivity of each TF
was calculated and summarized in Table 5. HNF3,
ETSF, SREBP, CEBP, GATA and IRFF were the most
common TFBSs across the three lipid clusters with the
highest connectivity in the network. Using this method,
we linked the TFs to their potential target genes in
three lipid clusters in the order of confidence score
(Additional files 2, 3, 4). The TFBS of SREBP, HNF3
and CEBP are commonly enriched in all three lipid
related clusters and share many downstream targets.
Additional files 5, 6, 7 listed top ranked potential targets
for SREBP, CEBP and HNF3 according to the confi-
dence score from the integrative analysis of three lipid
related clusters. Within the top 100 predicted targets for
CEBP, SREBP and HNF3, 49 were common between
SREBP and CEBP, 44 were common between CEBP and
HNF3, and 35 were common between SREBP and
HNF3; suggesting complex crosstalk and interactions
Table 4 TF-TG functional similarity and expression correlation (CEBPA and SREBP) (Continued)
Fah Slc34a2 Stat3 Lphn3
Mapk14 Kumar et al.
2003
Prdx6 Aytl2 Lpcat1
Cyp4v3 Fabp5 Ets1 Scd2 Tabor et al.
1999
Elovl1 Ier3 Exosc7 Emp2
Qk Lefterova et al.
2008
Scd1 Christy et al.
1989
Elovl1 Hc
Rcan1 Cd55 Fos Cyp4v3
Exosc7 Exosc7 Ggcx Mid1ip1
Gadd45g Kdr Klf9 Lyz
Correlation: the expression profile similarities between TF and genes in the same cluster were calculated using Pearson Correlation and ranked accordingly from
high to low based on the correlation coefficient. The top 40 genes with the highest correlation with Cebpa and Srebf1 are listed in Table 4.
Kappa similarity was calculated to estimate functional similarity between TF and genes based on the shared annotation terms. TF-TG functional association were
ranked from high to low based on the Kappa value. The top 40 genes sharing the highest functional annotations with Cebpa and Srebf1 are listed in Table 4.
We collected the positive TF-TG relationships from Ingenuity knowledge base (Ingenuity), Transfac 11.3 (Biobase), Eldorado (Genomatix) and PubMed. References
for the known TF-TG relationships are listed in the table.
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lipid network.
This method enables identification of genes of interest
and their regulators in rank order of their confidence
level (Table 6). For example, Abca3 is predicted to be
regulated by TFs in the order of SREBP1, HNF3
(FOXA1/2), TTF1, EGR (EGR1), E2F (multiple family
members) and CEBPA. ABCA3 is a known phosphati-
dylcholine transporter and plays an essential role in pul-
monary surfactant lipid metabolism and lamellar body
biogenesis [38,39]. ABCA3 mutations are associated with
surfactant deficiency and fatal respiratory distress syn-
drome [40-42]. Our previous studies showed that Abca3
gene expression was regulated by SREBP, CEBPA and
FOXA2 [12,13,43]. Abca3 promoter activity was regu-
lated by both lung selective TFs including TTF1,
CEBPA and FOXA2 and the lipogenic TF SREBP1. The
direct binding of SREBP1c to Abca3 promoter was con-
firmed by ChIP assay [44]. Thus Abca3 expression is
regulated by both cis-acting cassettes, providing a
mechanism by which surfactant and lipid homeostasis
may be integrated at the transcriptional level [44]. In
addition to known regulators, our model predicts EGR
and E2F as potential important regulators for Abca3
expression. ELOVL1 encodes a microsomal enzyme
involved in tissue-specific synthesis of very long chain
fatty acids and sphingolipids [45,46]. Little is known
about Elovl1 expression regulation other than that its
mRNA expression is correlated with SREBP1 in brown
adipocytes [47]. Elovl1 was grouped in Clusters 1 and 2,
together with Abca3 and our analysis predicts its control
by SREBP, CEBP, HNF3, TTF1 and TCF4, sharing simi-
lar regulation with Abca3. Slc34a2 encodes Na(+)/Pi
cotransporter 2B (NPT2B), is expressed most strongly in
lung and only in apical membrane of alveolar type II
Table 5 Summary of TF connectivity
TFBS Total
Connectivity
C1 C2 C28 TF in Lung
CEBP 447 238 51 158 Cebpa, Cebpb, Cebpd,
Cebpg
IRFF 404 239 0 165 Irf1, Irf2, Irf3, Irf5, Irf7
HNF3 359 228 51 80 Foxa1, Foxa2
GATA 358 218 44 96 Gata6, Gata1
ETSF 344 172 14 158 Ets1, Ets2, Etv5, Nfe2l2, Elf2
SREB 312 162 43 107 Srebf1
FOXO 268 151 0 117 Foxo1, Foxo4, Foxo3a
FKHD 213 95 25 93 Foxf2, Foxc1
HAND 201 94 0 107 Lmo2
STAT 182 0 0 182 Stat6, Stat3
MEF2 176 110 0 66 Mef2a
NFAT 169 0 0 169 Ilf3, Nfatc3
CP2F 168 83 0 85 Atf4, Tcfcp2, Atf3, Atf1
NFKB 166 78 0 88 Nfkb1
EREF 165 113 0 52 Esrra
LEFF 150 97 0 53 Lef1
HFH 134 75 19 40 Foxf1a, Foxi1
PARF 134 134 0 0 Tef, Tead1
AP1R 129 60 0 69 Nfe2
LEFF 121 87 34 0 Tcf4
CIZF 117 117 0 0 Znf384
HAND 113 43 0 70 Tcf12
BARBIE 111 98 13 0 Unknown
NKXH 106 68 38 0 Nkx2-1
SORY 104 93 11 0 Sox5, Sox9
NR2F 98 37 20 41 Hnf4a, Nr2f1, Nr2f2
OCT 92 92 0 0 Pou2f1, Pou6f2
CREB 79 0 10 69 Creb1
MYOD 74 0 0 74 Myog
NKX7 62 39 0 23 Nkx6-2
EBOX 59 0 21 38 Tcf4, Max
P53F 57 0 0 57 Trp53
RORA 57 0 0 57 Rora
HAML 54 0 0 54 Runx2, Pebp1
RXRF 54 0 0 54 Nr1h2
GREF 48 48 0 0 Nr3c1
BRN5 46 25 0 21 Pou6f1
HESF 46 0 20 26 Hes1
EGRF 45 0 45 0 Egr1, Wt1
HOXH 44 0 0 44 Meis1
SPIF 39 0 39 0 Klf11
HNF1 38 0 38 0 Hnf1a, Hnf1b, Hmbox1
E2FF 33 0 33 0 E2f1, E2f2, E2f3, E2f4, E2f5,
E2f7
SMAD 23 0 23 0 Smad4
Table 5 Summary of TF connectivity (Continued)
ZBPF 23 0 23 0 Zfp219
NKX6 22 22 0 0 Nkx6-1
LXHF 21 21 0 0 Lxh3
AP2F 19 0 19 0 Tcfap2c
PTBP 19 0 19 0 Tbp
GLIF 16 0 16 0 Zic2
BCDF 15 0 15 0 Crx
SPZ1 11 0 11 0 Spz1
PAX2 10 0 10 0 Pax2
MTF1 9 0 9 0 Mtf1
ZF5F 8 0 8 0 Zfp161
We calculated the confidence score based on the integrative evidence of TF-
TG relationship. Using the cut off confidence score of 0.5, the overall
connectivity of each TF to its potential TGs within three clusters were
calculated and summarized in Table 5. The corresponding TFs expressed in
lung were also listed.
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Page 8 of 19cells, the cells that produce and secrete surfactant.
Because of this localization, it was proposed that the
function of the gene product is to take up phosphate
from the alveolar fluid [48,49]. Mutations in SLC34A2
cause pulmonary alveolar microlithiasis [48,50]. We uti-
lized transient transfection promoter assays and con-
firmed the activation of Elovl1 and Slc34a2
transcription by both SREBP1 and CEBPA (see data
validation section). DLK1 encodes an EGF like homeo-
tic transmembrane protein that acts as a negative regu-
lator of Notch1 and adipocyte differentiation [51,52].
Our analysis predicts its control by CEBP, HNF3,
SREBP1, EGR1, HNF1 and GATA1. Both Elovl1 and
Dlk1 are highly enriched in alveolar type II cells. Based
on the present model, we hypothesize that genes such
as Slc34a2, Dlk1 and Elovl1 may share similar tran-
scription regulation with Abca3 in the lung where they
are likely to influence surfactant metabolism.
Construction of a lipid gene regulatory network in the
mouse lung
Al u n g“Lipid gene regulatory network” was generated
by combining the predicted TF-TG relationships from
the three clusters. In Figure 2, we show a sub-network
consisting of the TFs with the highest connectivity
(score ≥0.6, top 4.5%) among three gene clusters.
SREBP, HNF3, ETSF, CEBP, GATA and IRFF are clear
regulatory hubs in this network, these TFs are likely to
be key regulators controlling surfactant lipid homeosta-
sis in the lung via the regulation of genes within the
three lipid-related clusters. The roles of several key TFs
in the proposed network have been partially confirmed
by previous studies from our group and others, includ-
ing SREBP1, FOXA2, CEBPA, ETV5 and GATA6
[12,13,43,53-55]. IRF1 encodes interferon regulatory
factor 1, a member of the interferon regulatory tran-
scription factor family. The finding that IRF may serve
as an important regulator in lung lipid homeostasis
merits further experimental validation. The finding that
previously experimentally validated transcriptional reg-
ulators of surfactant homeostasis were identified as key
hubs in present unbiased network, strongly support the
reliability of our proposed model.
Due to the complexity and modularity of the biologi-
cal networks, we have focused on several important
sub-networks. Figure 3 depicts the CEBPA-SREBP cen-
tered sub-network. 3A represents top ranked common
gene targets for CEBP and SREBP and 3B represents
top ranked unique gene targets for CEBP and SREBP.
Many known markers of lung maturation and function,
including SFTPB, ABCA3, AQP5, LPCAT SMAD5,
ETV5 (Erm) and VEGFA are predicted to be co-regu-
lated by SREBP and CEBPA. Further studies are needed
to understand how the proposed interactions between
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Page 9 of 19SREBP and CEBPA control lung maturation. A subset
of predicted targets whose regulation was unknown
previously was experimentally confirmed by in vitro
promoter reporter assays (Figure 4).
Experimental validation of predicted TF-TG relationships
Network prediction was validated through promoter
reporter assays, transgenic animal models and literature
confirmation. Since the integrative analysis predicted
SREBP, CEBP and HNF3 as key regulators in the lipid
related transcription network in lung, we focused on
these three TFs to validate the network predictions
derived from the bioinformatics analysis.
Gene promoter assays were carried out on selective
TF-TG pairs utilizing the following selection criteria: 1)
confidence score, prioritizing top ranked gene targets of
SREBP and CEBP, 2) tissue and cell specificity i.e. lung
epithelial type II cell enrichment and subcellular loca-
tion in endoplasmic reticulum or Golgi, 3) functional
annotation that is lipid related and 4) originality, seeking
novel targets with new function. Applying these criteria,
we selected the first set of candidate genes likely modu-
lating lipid homeostasis in the lung epithelial cells,
including Elovl1, Slc34a2 and Zdhhc3,t h e i rf u n c t i o n a l -
ity, expression and subcellular location as listed in Table
7. Figure 4 shows the promoter-reporter assays using C/
EBPa and SREBP1c cotransfected with ~1 kb Elovl1,
Slc34a2 and Zdhhc3 promoter-luciferase constructs in
mouse lung epithelial cells (MLE-15)[56,57]. Consistent
with our prediction (Table 6 and Additional files 2, 3,
4), CEBPA and SREBP1c activated Elovl1 and Slc34a2
promoters; Zdhhc3 was only regulated by SREBP1c but
Figure 2 Graphic representation of a subnetwork consisting of predicted TF-TG pairs with the highest connectivity. The graphic
representation of a subnetwork consisting of predicted TF-TG pairs with confidence cutoff as 0.60 and the top 6 TFs with the highest
connectivity. SREBP, HNF3, ETSF, CEBP, GATA and IRFF were identified as regulatory hubs in this network. The network has 183 nodes and 386
links. Round nodes represent TGs, red diamond nodes represent TFs. Blue edges indicate the TF-TG predictions from C1, red edges for C2, green
for C28, yellow for both C1 and C2, brown for both C1 and C28, light blue for both C2 and C28, and pink edges for TF-TG predication from C1,
C2, and C28. The thickness of the edge corresponds to the frequency of the TF-TG prediction from all three clusters.
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Page 10 of 19not by CEBPA. The functions of Elovl1 and Zdhhc3 in
lung biology are unknown whereas Scl34a2 has recently
been linked to alveolar microlithiasis[48,50].
Transgenic mice were used in conjunction with
mRNA microarray to identify genes and processes regu-
lated by TFs and signaling molecules. The correlation
between the genomic response of selective TF perturba-
tion using transgenic mouse models and the integrative
prediction derived from the present study provide
in vivo evidence for the predicted TF-TG regulatory
relationships. We compared predicted SREBP, HNF3
and CEBP targets with the genes differentially expressed
in the lung after selective deletion of Scap (SREBP
cleavage-activating protein), Foxa2 and Cebpa from
respiratory epithelial cells[43,58]. These three arrays
were not included in previously array analysis and net-
work development, therefore can be used as indepen-
dent data for validation. Genes with high confidence
s c o r e( s c o r e> 0 . 5 5 )w e r eu s e da sp o s i t i v ep r e d i c t i o n ,
genes with low confidence score (score <0.45) were used
as negative control. Based on the binomial probability
calculation, predicted gene targets showed significant
overlap with genes responsive to the deletion of the
respective TFs in vivo (p-value for SREBP: 1.03E-08,
p-value for FOXA2: 0.0037, p-value for CEBPA: 1.61E-05).
Within the top 100 ranked candidate targets for CEBP
Figure 3 Graphic representation of a CEBPA-SREBP centered sub-network. The graphic representation of a CEBPA-SREBP centered sub-
network, showing the potential connections between SREBP, CEBPA and their predicted gene targets. 3A represents top ranked common gene
targets for CEBP and SREBP and 3B represents top ranked unique gene targets for CEBP or SREBP. Solid line represented literature-validated
relationships and dotted lines represent predicted relationships. Known markers of lung maturation and function are highlighted in purple.
Figure 4 Promoter reporter assay of predicted C/EBPA and SREBP targets in transient transfection of MLE-15 cells.S c h e m a t i c
representation of the ≥1k bSlc34a2, Elovl1 and Zdhhc3 promoter-luciferase constructs made in pGL3 reporter plasmids are depicted above the
graphs. C/EBPa (green) and SREBP1c (red) represent consensus motifs on each mouse gene promoter. Transcription start sites are shown at +1
bp. The dose response effects of C/EBPa and SREBP1c expression after co-transfection with fixed amounts of the promoter-reporter constructs
were assessed in MLE-15 cells, an immortalized mouse lung epithelial cell line, as measured by luciferase activity in 6-well plates. Values
represent two independent experiments carried out in duplicate with means ± S.D. (n = 6).
Xu et al. BMC Genomics 2010, 11:451
http://www.biomedcentral.com/1471-2164/11/451
Page 11 of 19(Cebpa/b/g), 35 mRNA were decreased in response to the
Cebpa deletion in the lung in vivo. Likewise, within the
top 100 ranked candidate targets for SREBP (Srebf1/2), 25
mRNAs decreased in response to the Scap deletion in
vivo; and within the top 100 ranked candidate targets for
HNF3 (Foxa1/2), 21 mRNAs were decreased in response
to the Foxa2 deletion (Additional files 5, 6, 7). These
results provide evidence that SREBP, HNF3 and CEBPA
regulate the predicted gene targets expression in lung
in vivo.
Literature mining provides another resource to vali-
date computational predictions for the enriched TFs and
their potential target genes in the three lipid clusters
identified in the present study. We used MedScan
Reader, a Natural Language Processing (NLP) text-
mining tool [59] (Ariadne Genomics) to search the
entire PubMed database. For each TF - TG pair, this
algorithm extracts various types of regulatory mechan-
isms and the effects of regulation by recognizing differ-
ent domain-specific named entities in the input text and
extracting functional relationships among them. As indi-
cated in Additional files 5, 6, 7, all experimentally con-
firmed SREBP targets were ranked in the top 5% of our
predictions; all confirmed HNF3 targets were ranked in
the top 10% of our predictions. In the case of CEBPA,
all of the experimentally confirmed CEBPA targets were
ranked within the top 30% of our prediction with the
score >0.5, 86% of them were ranked in the top 10% of
our prediction. CCAAT/enhancer binding proteins (C/
EBP) include multiple family members that bind to
CEBP binding sites with different affinities; that may
influence the precision of the present prediction.
Taken together, the consistency of results from
in vitro reporter assays, transgenic mice and literatures
Table 7 Functionality and subcellular location of selected genes
Symbol Description Expression & Subcellular
Location
Function Disease
Elovl1 Elongation of very
long chain fatty acid
protein1
Expressed in lung type II
cells. Endoplasmic Reticulum
Membrane
Tissue-specific synthesis of very long fatty acids
and sphingolipids. May catalyze the conversion
of beta-ketoacyl CoA to beta-hydroxyacyl CoA
or Reduction of trans-2-enoyl CoA to the
saturated acyl CoA derivative.
Parkinson’s disease
Slc34a2 Solute carrier family 34
(sodium phosphate),
Member 2
Apical Membrane of Type II
cells
Actively transporting phosphate into cells via Na
+ cotransport. May have a role in the synthesis
of surfactant in lungs’ alveoli.
pulmonary alveolar microlithiasis,
ovarian cancer
Soat1
(Acat)
Sterol O-acyltransferase
1
Expressed in lung type II
cells. Endoplasmic Reticulum
Membrane
Catylyzes the formation of fatty acid-cholesterol
esters. Plays a role in lipoprotein assembly and
dietary cholesterol absorption.
atherosclerosis
Zdhhc3
(Godz)
Palmitoyltransferase
Zinc finger DHHC
domain-containing
protein 3
Expressed in lung type II
cells. Golgi apparatus
Palmitoyltransferase with broad specificity;
membrane protein trafficking
Lpcat1
(Atyl2)
Acyltransferase-like 2
Phosphonoformate
immuno-associated
protein 3
Expressed in lung type II
cells. Endoplasmic Reticulum
and Golgi Apparatus
Membrane
Mediates the conversion of 1-acyl-sn-glycero-3-
phosphocholine (LPC) into phosphatidylcholine
(PC). May synthesize phosphatidylcholine in
pulmonary surfactant, play a pivotal role in
respiratory physiology.
migraines
Stard4 START domain-
containing protein 4
Expressed in lung type II
cells. Mitochondria.
May be involved in the intracellular transport of
sterols or other lipids. May bind cholesterol or
other sterols
Huntington’s disease
Dlk1
(DLK)
Protein delta homolog
1
Expressed in lung type II
cells. Membrane
May function in adipocyte differentiation and in
neuroendocrine differentiation
lung cancer, bronchiolo-alveolar
adenocarcinoma,
blepharophimosis, obesity,
neoplasia, hypertriglyceridemia
Prdx6 Peroxiredoxin 6 Expressed in lung type II
cells. Cytoplasm, Lysosome,
lung secretory organelles.
Involved in redox regulation of the cell. Can
reduce H(2)O(2) and short chain organic, fatty
acid, and phospholipid hydroperoxides. May
play a role in the regulation of phospholipid
turnover as well as in protection against
oxidative injury
acute allergic pulmonary
eosinophilia, asthma, follicular
adenoma, Huntington’s disease,
neoplasia
Abca3 ATP-binding cassette,
sub-family A (ABC1),
member 3
Expressed in lung type II
cells. Membrane
Plays an important role in the formation of
pulmonary surfactant, probably by transporting
lipids such as cholesterol
surfactant metabolism
dysfunction, inflation, respiratory
failure, atelectasis
Type II cell expression information is obtained from PBGE DB. Subcellular location is based on Gene Ontology http://amigo.geneontology.org/ DB and GeneCard
http://www.genecards.org/. Protein function is based on Uniprot Knowledgebase http://www.uniprot.org/uniprot/. Disease information is based on the Ingenuity
knowledgebase (Ingenuity) and Genecard http://www.genecards.org/.
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potential utility for predicting important TF-TG rela-
tionships in the proposed transcription regulatory
network.
Biological implication of the lung lipid transcription
networks
In the present study, we identified both general and
context dependent regulators of lung lipid homeostasis
related to pulmonary surfactant. The TFBS of SREBP,
HNF3B and CEBP are commonly enriched in all three
lipid related clusters and share many downstream tar-
gets. We hypothesize that SREBP, CEBP and HNF3
family of TFs form core regulatory modules to maintain
surfactant production. Consistent with our model, pre-
vious studies demonstrated that the deficiency of hepatic
C/EBP in leptin-deficient mouse leads to impaired
SREBP signaling [60], C/EBPa and SREBP-1 form com-
plexes in hepatocytes and synergistically regulate the
transcription of lipogenesis associated genes such as
Acly and Acss2 [6]. Recent work from Payne et al. [17]
demonstrated that SREBP-1c is directly regulated by C/
EBP factors during adipocyte differentiation (a, b and δ)
and C/EBPa plays a critical role in regulating SREBP-1c
in the later stages of adipogenesis (adipocyte matura-
tion). In the lung, C/EBPa a n dS R E B P - 1 cp l a yi m p o r -
tant roles in alveolar type II cells lipogenesis [19].
FOXA2 interacts with C/EBPa in mouse liver [61],
FOXA2 is necessary for normal expression of C/EBPa
in embryonic mouse lung epithelial cells [12].
Core TFs may cooperate with other factors in a con-
text dependent manner. In addition to “lipid metabo-
lism”, SREBP is associated with target genes involved in
other related biological processes in cooperation with
other TFs. TTF-1 (gene symbol: Nkx2-1) plays a central
role at various stages of lung development, essential for
lung cell differentiation, maturation and proliferation,
and for the production of surfactant proteins. TTF-1
binds to the promoters of lung specific genes such as
Sftpa, Sftpb, Sftpc, Sftpd and Scgb1a1 and increases their
expression [10,15,53,55,62,63]. The effects of TTF-1 are
likely mediated by its interactions with other TFs and
co-activators, including WWTR1 (also known as TAZ
[10]), GATA6 [55], RAR [64], NFATC3 [57] and NFI
[65]. In the present study, TTF-1 is enriched in Clusters
1 and 2, sharing many targets with SREBP to control
lipid and surfactant biosynthesis and transport (Abca3,
Prdx6, Sftpa1, Sftpb, Sftpc, Dlk1 and Elovl1), Apoptosis
(Ahr, Bex2, Fli1, Id2, Mef2c and Runx1t1), transcription
regulation (Ahr, Bcl6b, Cebpa, Elf5, Etv5, Foxa2, Jun,
Sox7 and Wwtr1) and respiratory disease (Abca3, Aqp5,
Cftr, Dlk1, Kdr, Prdx6, Sftpa, Sftpb, Sftpc and Slc34a2).
Among these, predicted targets such as CEBPA,
FOXA2, WWTR1, JUN, ABCA3, SFTPA and SFTPB
have been identified as interaction partners or transcrip-
tional targets of TTF-1[12,44,63,66-68]; targets like
AHR, CEBPA, ID2 and DLK1 have the same relation-
ships with SREBP[69-73], but little information is avail-
able regarding combinatorial regulation of targets by
multiple transcription factors.
EGR is uniquely enriched in Cluster 2 genes (lipid
cluster). EGR-1 belongs to C2H2-type zinc-finger pro-
tein family and activates genes required for differentia-
tion and mitogenesis. In lung, EGR-1 plays a key role in
the pathogenesis of IL-13-induced inflammatory
responses [74]. The role of EGR-1 in lipid metabolism is
unknown. Present study identified a number of EGR
and SREBP shared common targets that associated with
lung disease or function (Abca3, Aqp5, Foxa2, Cebpa,
Kdr and Sftpb), lipid metabolism (Abca3, Soat1, Dlk1,
Scd1, Scd2, Lpcat1 and Fabp5), cell growth and prolif-
eration (Btg3, Dlk1, Emp2 and Pdia5). Among these,
Scd1 and 2 are known target of SREBF1 [75], their
mRNA expression are also dependent on EGR2 [76].
SCD and FABP5 are known to play important roles in
lung specific phospholipids/surfactant biosynthesis
[19,77]. LPCAT1 encodes lysophosphatidylcholine acyl-
transferase catalyzing the conversion of lysophosphati-
dylcholine to phosphatidylcholine in the remodeling
pathway of phatidylcholine biosynthesis [78]. LPCAT1 is
highly expressed in lung type II cells and plays a critical
role in regulating surfactant phospholipid/surfactant bio-
synthesis [79].
Known disease associated genes were identified through
the present network analysis. As predicted in Figure 3,
ABCA3, DLK1, VEGFA, AGER, SLC34A2 and surfactant
proteins are co-regulated by SREBP and CEBPA. Defi-
ciency or mutation of surfactant proteins and ABCA3
cause interstitial lung disease and respiratory failure
[40,41,80], PRDX6 is associated with allergic pulmonary
eosinophilia and asthma [81,82], DLK1 is associated with
bronchiolo-alveolar adenocarcinoma and lung cancer [83],
VEGFA (vascular endothelial growth factor A) and KDR
(VEGFR, a member of VEGF receptor) play important
roles in lung maturation [84] and pulmonary hypertension
[85], AGER (advanced glycosylation end product-specific
receptor, also known as RAGE) is associated with acute
allergic pulmonary eosinophilia [81], and mutations of
SLC34A2 cause pulmonary alveolar microlithiasis [50].
The finding that the present approach identified genes and
processes associated with human lung disease indicates
its potential utility for the discovery of new genes and
biomarkers that may be useful in understanding the
pathogenesis of lung disorders.
Conclusions
We employed a systems biology approach to begin map-
ping a transcriptional network regulating surfactant
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TFs, signaling molecules and potential target genes
within the network. SREBP, CEBP, HNF3, ETS, GATA
and IRF were identified as regulatory hubs with high
connectivity. We propose that SREBP, HNF3B and
CEBP form a common core regulatory module mediat-
ing surfactant lipid homeostasis. These key TFs likely
interact with other TF partners to regulate lung growth
(OCT and NFKB), differentiation and maturation (TTF1
and EGR1), pulmonary host defense and inflammatory
responses (IRF, NFAT and STAT). The present study
provides a systematic view and working model of a tran-
scriptional network regulating the formation and meta-
bolism of the pulmonary surfactant system.
The current approach also has several important lim-
itations. The approach is unlikely to identify epigenetic,
post-transcriptional and gene-environmental interactions
that may play important roles in gene regulation [23,24].
L i k e w i s e ,w eh a v en o te m p h asized the study of enzy-
matic transport activities of the many enzymes and pro-
teins identified in the network. All these will be
important for our long-term understanding of lung lipid
homeostasis, but are beyond the scope of the present
study.
Methods
Data Collection, processing and storage
We have developed a relational database to store, man-
age and maximally utilize gene expression profile data
collected from multiple investigators in Cincinnati Chil-
dren’s Hospital Medical Center, Division of Pulmonary
Biology. We analyzed 194 microarray samples from 27
independent microarray experiments in this study
(Table 1). Data was normalized using the Robust Multi-
chip Average model [86] from R/Bioconductor package.
The detection of differential expression was preformed
using unpaired two-group Student’st - t e s tf o rm u t a n t
and control at the P value ≤ 0.05. Additional filters for
positive candidate selection include a minimum of 1.5
fold change in absolute ratio and a minimum of 67%
Present call by Affymetrix algorithm. We identified 1498
genes that significantly changed in response to the gene
perturbations in at least 5 experimental conditions. The
full gene set derived from mRNA profiling is listed in
Additional file 1.
Cluster analysis
Clustering is a powerful way to explore complex gene
expression data by grouping them on the basis of simi-
larity of their expression patterns. We compared meth-
ods among K-means, QT clustering and Fuzzy Heuristic
Partition [87,88] in this study. Only Fuzzy Heuristic Par-
tition allows genes to be assigned to more than one
cluster with different degrees of membership. At a very
stringent membership cutoff, most of the genes in each
cluster were highly correlated across all experimental
conditions. As the membership cut-off decreases, addi-
tional genes were assigned to the cluster based on their
expression similarity on a subset of experimental condi-
tions. This enables the identification of context-depen-
dent regulation. We further clustered differentially
expressed genes using Fuzzy clustering by local approxi-
mation of membership algorithm [87] with parameter
setting -KNN: 7; Max App: 500; Membership Range:
35%. We evaluated the clustering performance based on
its ability to produce biologically meaningful clusters
using the Gene Ontology database as a common refer-
ence [89,90].
Functional classification
After identifying co-expressed gene groups, we sought to
identify the potential biological themes represented by
these distinct gene sets. Such processes are helpful in
assigning the functional linkage to gene groups and the
evaluation of clustering quality. Genes in each cluster
were uploaded to DAVID, a pre-compiled web-based
functional annotation tool [91] for gene ontology analy-
sis. For each GO term, a Fisher’s exact test was used to
compare the occurrence of the term in the list of inter-
est and the rest of the genome as a reference list to
identify over-represented functional categories in each
gene list. For genes within a cluster, Kappa similarity
was measured to estimate functional similarity between
genes based on the number of shared annotation terms
[33]. A TF-TG Kappa similarity matrix was created with
each value ranging from 0 to 1, the higher the value of
Kappa, the stronger the overall agreement in annotation
terms.
TF-TG Correlation
We consider TFs in a given cluster as “candidate regula-
tors” of that cluster. The expression profile similarity
between TF and genes in each cluster were calculated
using Pearson Correlation and a TF-TG correlation
matrix was generated with each value ranging from +1
to -1, indicating the perfect positive and negative corre-
lation, respectively.
Identification of common TFBS motif and module
Motif search is often associated with a large number of
false positive predictions due to the short and degener-
ate nature of many TFBS motifs. Several approaches
were used to reduce false positives and improve the pre-
diction accuracy. 1) Apply comparative genomics: Gen-
ome RVista http://genome.lbl.gov/vista/ and DiRE
http://dire.dcode.org were used to identify evolutionarily
conserved regulatory elements that were over-repre-
sented in our co-expressed gene clusters [28,31,92].
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(ECR) via human and mouse whole genome alignment.
The locations of putative TFBSs were precomputed for
each genome using vertebrate position weighted
matrices from TRANSFAC matrix library version 10.2.
For Genome RVista, we chose conserved TFBSs located
3 kb upstream of transcription start site with the
p-value cutoff at 0.005. For DiRE, we chose conserved
TFBSs from the top three conserved ECRs (which can
be located in intron, UTR or intergenic regions) and the
promoter ECRs. Over-represented TBFSs from both
programs were combined for further analysis. 2) Search
for over-represented TFBSs in proximal promoter
region: since the majority of functional TFBSs are found
in the promoter region of eukaryotic genomes, cis-ele-
ment over-representation (Clover) [93] was used to
determine the conserved TFBSs that were over-or
under-represented in the given promoter set. 3) Search
for Cluster and composite of TFBSs: Since it is known
that TFBS are not evenly distributed, finding motif
peaks within the promoter region is likely to indicate
functional regulatory regions. Cluster-Buster, a Hidden
Markov Model based method [93] was used to identify
clusters of pre-specified motifs in a given gene cluster.
Perl scripts were used to extract common composite
sites from the motif clusters identified by Cluster-Buster
algorithm. For approaches in 2) and 3), we used proxi-
mal promoter sequences of genes in the cluster of inter-
est (1 kb up stream and 200 bp downstream of TSS,
Ensembl release, version 52). We used MousePromo-
ters_v19 from Ensembl release 19.32 as the background
set, which contains 20,028 mouse promoters of the
same region. 4) Both TRANSCompel database [94] and
Matbase (Genomatix) contain well documented, experi-
mentally confirmed promoter modules with synergistic,
antagonistic, or additive functions. Comparison with
these prior known TF modules can be used to identify
and verify meaningful TFBS combinations.
T h er e l a t i v ei m p o r t a n c eo faT F B Si sd e t e r m i n e db y
the average ranking order of ECR, prompter and fre-
quency analysis. A TFBS-TG matrix was derived from
promoter mining. The score between a TFBS, Ti and a
gene, Gj, is defined as TFBS (Ti, Gj) Î < 0,1,2>. 0
means that Ti is not present in the promoter of Gi;1
means the presence of a single Ti in the conserved pro-
moter regions of Gi; 2 means the presence of multiple
Ti in the conserved promoter regions of Gi.
Knowledge Base and Interaction Search
We collected the positive TF-TG relationships from:
Ingenuity knowledge base (Ingenuity), Transfac 11.3
(Biobase) [94], Eldorado (Genomatix), PReMod [95],
protein interaction databases HPRD [96] and BioGRID
[97]. A TF-TG interaction matrix was formed from the
combined resources. Interaction score is defined as
Interaction (Ti, Gj) Î < 0, 1, 2, 3> The higher the score,
the more certainty the TF-TG relationship: 0 means no
evidence, 1 indicates the evidence from high throughput
screen or computational prediction or gene co-citation
from databases ≤10. 2 means supporting evidence is
from more than one resources and gene co-citation ≥10.
3 means direct experimental evidence or evidence from
multiple resources.
Data Integration
W ec a l c u l a t e dt h er e l a t i v ec o n f i d e n c es c o r eo fT F - T G
associations by combining the data obtained. One key
assumption of our integrative approach is that TGs shar-
ing expression and functional similarity are likely to be
regulated by the same TF(s), and TFs sharing expression
and functional similarity are likely to form functional
modules to regulate the same group of TG(s). We
grouped TF using hierarchical clustering, according to an
integrated matrix compiled from four types of data
sources: a TFBS-TG scoring matrix, a TF-TG functional
similarity matrix, a TF-TG expression correlation matrix
and a TF-TG interaction matrix. Each value in the four
matrices was scaled from 0 to 1 and summed into the
integrated TF-TG matrix. The TF-TG matrix was further
normalized and scaled between 0 and 1, denoted as Score
(Ti, Gj). We grouped TGs into sub-clusters using hier-
archical clustering, based on an integrated matrix, com-
bining and capturing information from four data sources:
gene expression, TF-TG correlation, promoter TFBS pre-
diction and GO functional similarity. In the integrated
matrix, each row represents a gene, and each column
represents a feature from one of the four matrices.
We define Support between each TF cluster Ct and
each TG cluster Cg as
Support Ct Cg
Score Ti Gj
n
i
m
(, )
(, )
, =
⋅
= = ∑ ∑
j
mn
1 1
where Score(Ti, Gj) is from the integrated matrix
between TF and TG, m is the size of Ct, n is the size of
CgTi Î Ct, and Gj Î Cg.
Support describes the connectivity between a TF clus-
t e ra n dag e n ec l u s t e r .T h ev a l u eo fSupport ranges
from 0 to 1. Given a threshold of Support,f o ri n s t a n c e ,
0.25, satisfying TF-TG cluster pairs are extracted as cor-
related cluster pairs. Given a correlated cluster pair, we
further define Confidence between TF-TG pairs within
this cluster pair as
Confidence Ti Gj
Score Ti Gj
n
Score Ti Gj
m
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j
n
i
m
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Page 15 of 19where L(Ti, Gj) is calculated by scaling Score(Ti, Gj)
into [0.5, 1]. I(Ti) is normalized relative TF importance
ranging from [0.8, 1.2]. m is the size of Ct, n is the size
of Cg, Ti Î Ct and Gj Î Cg,a n dCt and Cg are in a clus-
t e rp a i rp a s s e dSupport cutoff. All factors are equally
weighted in the equation.
Confidence describes the possibility of a true positive
TF-TG relationship according to the integrated informa-
tion. The first factor of Confidence (Ti, Gj) denotes the
connectivity between a Ti from a cluster Ct and all
genes in a cluster Cg, the second factor measures the
connectivity between a Gj from cluster Cg and all TFs
in cluster Ct, the fourth factor implies the connectivity
between Ti and Gj, and the fifth factor I(Ti) denotes the
relative importance of Ti in our analysis. We rank
TFBS-TG pairs based on the normalized Confidence
score for each TF-TG pair. The TFBS-TG pairs with the
highest Confidence scores will be selected for experi-
mental validation. For each cluster, we generated a TF-
TG association table ranked according to the confidence
score. A network graph linking TFs and their TGs was
generated using Cytoscape 2.6 http://www.cytoscape.
org/.
Cell Culture, Transfection, and Reporter Gene Assays
The MLE-15 cell is an immortalized mouse lung epithe-
lial cell line that maintains some of the morphological
and functional characteristics of type II epithelial cells.
MLE-15 cells were cultured in HITES medium [56] for
functional characterization of mouse Elovl1, Slc34a2 and
Zdhhc3 promoters. Approximately 1 Kb of the 5’-
upstream regulatory regions comprising the proximal
promoter were PCR amplified, including the transcrip-
tion start site (TSS) and a part of the 5’-untranslated
(5’-UT) region as depicted in Figure 4. The promoter
fragments were confirmed by sequencing from both
ends and cloned to generate promoter-luciferase vectors
in pGL3-basic plasmid (Promega) and used in transient
transfection assays using Fugene 6 at a DNA/Fugene
ratio of 1:3 according to the manufacturer’s instructions
(Roche Applied Science). Briefly, 6-well plates at 30-50%
confluence were transfected with a fixed amount of each
promoter-luciferase plasmid and various amounts of
CMV-based cDNA expressing transactivator plasmids
mouse C/EBPa (kind gift from Dr. Mcknight, University
of Texas Southwestern Medical Center at Dallas) or
human SREBP1c [98]. Total DNA was normalized with
corresponding CMV-empty vectors, and transfection
efficiency was normalized to b-galactosidase activity
using 100 ng/well of pCMV b-galactosidase. Two days
after transfection, luciferase and b-galactosidase assays
were performed using 20 μl of the supernatant accord-
ing to a previous protocol [55]. The light units were
assayed by luminometry (Berthold Technologies GmbH
& Co., Calmbacher, Germany). Data obtained represent
the average of three transfection experiments, each
carried out in duplicate (n = 6) and depicted as means
± S.D. unless stated otherwise.
Availability
All published microarrays and mouse models we used in
this study are listed in Table 1 with references. Unpub-
lished microarray data used in this study are available
upon request. Perl scripts for extracting results from
Cluster-Buster and confident score calculation can be
freely downloaded from http://research.cchmc.org/pbge/
jsp/links_v2.jsp
Additional material
Additional file 1: Data collecting and Clustering.
Additional file 2: Support & Confidence Calculation For C1 Genes.
Additional file 3: Support & Confidence Calculation For C2 Genes.
Additional file 4: Support & Confidence Calculation For C28 Genes.
Additional file 5: Top Ranked CEBP Targets According To The
Integrative Score.
Additional file 6: Top Ranked SREBP Targets According To The
Integrative Score.
Additional file 7: Top Ranked HNF3 Targets According To The
Integrative Score.
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